CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Private Placement	Common Stock	Common Stock Private Placement	Additional paid in capital	Additional paid in capital Private Placement	Treasury stock	Accumulated deficit
Beginning balance, common shares (in shares) at Dec. 31, 2021			135,566,227
Beginning balance at Dec. 31, 2021	$ 122,368		$ 14		$ 253,744		$ 0	$ (131,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(18,825)							(18,825)
Equity-based compensation expense	3,858				3,858
Repurchase of shares as a result of Forward Share Purchase Agreements (in shares)			(9,952,803)
Repurchase of shares as a result of Forward Share Purchase Agreements	(57,350)						(57,350)
Ending balance, common shares (in shares) at Mar. 31, 2022			125,613,424
Ending balance at Mar. 31, 2022	$ 50,051		$ 14		257,602		(57,350)	(150,215)
Beginning balance, common shares (in shares) at Dec. 31, 2022	127,022,363		127,022,363
Beginning balance at Dec. 31, 2022	$ (37,872)		$ 14		272,528		$ (57,350)	(253,064)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(26,214)							(26,214)
Equity-based compensation expense	3,805				3,805
Issuance of Private Placement shares (in shares)				13,888,889
Issuance of Private Placement shares		$ 7,081		$ 2		$ 7,079
Issuance of shares for equity-based compensation awards, net (in shares)			911,861
Issuance of shares for equity-based compensation awards, net	$ (839)				(839)
Issuance of shares for exercised convertible notes (in shares)			94
Repurchase of shares as a result of Forward Share Purchase Agreements (in shares)							(9,952,803)
Repurchase of shares as a result of Forward Share Purchase Agreements							$ (57,350)
Ending balance, common shares (in shares) at Mar. 31, 2023	141,823,207		141,823,207
Ending balance at Mar. 31, 2023	$ (54,039)		$ 16		$ 282,573		$ (57,350)	$ (279,278)